The non-coding region (NCR) of the epidermodysplasia verruciformis (EV)-associated human papillomavirus 8 (HPV-8) has been investigated for sequencespecific DNA-protein interactions with nuclear proteins from epithelial HeLa cells. Using DNase I protection analysis 18 footprints could be found within the HPV-8 NCR, covering altogether over 60% of both DNA strands. Several footprints coincided with the known binding sites of transcription factors (NF1, API, octamer and PEA3 consensus sequences); the other displayed no obvious similarities in this regard.
Introduction
A growing body of evidence strongly suggests an active role of papillomaviruses in the natural history of some human malignancies. To date, the closest association between human papillomavirus (HPV) infection and the development of cancers has been observed for cervical neoplasias and squamous cell skin carcinomas of epidermodysplasia verruciformis (EV) (zur Hausen & Schneider, 1987; Jablonska, 1990) .
EV is characterized by life-long persisting fiat warts or maculous lesions, which undergo malignant conversion in 30 to 60 ~ of patients. The EV-specific skin lesions are induced by a group of at least 19 different HPV types. In contrast to the plurality in the benign tumours, only a few types (predominantly HPV-5 and -8) can be detected in EV carcinomas (Orth, 1987) . Except for HPV-3 and -10 all these viruses appear highly restricted in their pathogenicity to EV patients, although seroepidemiological evidence suggests a wide distribution in the general population (Steger et al., 1990) . This host specificity was originally ascribed to the impaired cell-mediated immunity of EV patients but an extensive screening of otherwise immunocompromised patients very rarely revealed EV-specific lesions. As an alternative possibility the pathogenicity of EV-associated HPVs may be controlled at the level of gene expression (Fuchs & Pfister, 1990 ).
HPV transcription is primarily regulated by elements within the non-coding region (NCR) of the viral genome. The majority of identified promoters as well as a number of transcription-modulating elements (enhancers, silencers) have been mapped to these sequences (Iftner, 1990) . In the case of HPV-8 the entire NCR has been shown to act as a transcriptional enhancer, dependent on transactivation by the viral E2 protein (Seeberger et al., 1987 ; Iftner et al., 1989) . A functional dissection of the HPV-8 NCR revealed this activity to be the net result of an interplay between several positive and negative modules (Reh & Pfister, 1990) . In contrast to HPV-8, no or only very low enhancer activity could be demonstrated for the NCR of HPV-19, which is exclusively associated with benign EV lesions (Fuchs et al., 1990) .
Comparative analyses of the NCRs from seven EVassociated virus types have shown a highly characteristic array of sequence elements of known or supposed regulatory importance that differ from the organization of other papillomaviruses (Krubke et al., 1987; Ensser & Pfister, 1990) . Besides several elements occurring in all papillomaviruses studied so far (E2-binding palindromes, CAAT box equivalents, NF1 and AP1 binding sites) a number of EV-specific sequence motifs such as M33, M29 and an A/T box have been found. Some differences, particularly within the A/T box, were noted between HPV-5, -8 and -36 on the one hand and HPV-19, -20 and -25 on the other (Ensser & Pfister, 1990 ).
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The aim of this work was to map DNA-protein interactions within the NCRs of HPV-8 and -19, with special emphasis on EV-specific sequences.
Methods
Cell culture and preparation of nuclear extracts. Human HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% foetal calf serum. The nuclear extracts were prepared from pooled subconfluent cultures according to Dignam et al. (1983) , as modified by Wildeman et al. (1984) and Sch61er & Gruss (1985) . The protein concentration in the extracts assayed by the method of Bradford (1976) was 12 to 20 mg/ml. Viral DNA and oligonucleotides. The NCR-containing EcoRI EcoR V (positions 7078 to 555) and NlalV-AluI (positions 7359 to 243) fragments of HPV-8 (Fuchs et al., 1986) were subcloned into plC19H and plC20R (Marsh et al., 1984) . The corresponding genomic region of HPV-19 (Gassenmaier et al, 1984) was subcloned as an EcoRI HindlII fragment into plC20R.
Oligonucleotides were synthesized with the Cyclone DNA Synthesizer (Biosearch (Boshart et al., 1985) ].
Footprinting techniques. Footprinting reactions were carried out on both strands of subfragments from the respective NCRs, 5'-or 3'-labelled with 32p and polyacrylamide gel-purified according to standard methods (Sambrook et al., 1989) . The footprinting reactions were stopped by adjusting the samples to 0.1 M-NaCI, 20 mM-EDTA, 0.5% SDS and 50 lag yeast tRNA/ml. The DNA was immediately extracted with phenol, ethanolprecipitated and analysed on 5 to 8% urea gels. A sequencing ladder generated by the chain termination method (Sanger et al., 1977) was used as a length standard.
DNase I protection analysis was performed essentially as described by Patel et al. (1989) . Briefly, up to 200 ~tg nuclear extract was mixed with 2 lag poly(dI-dC).poly(dI-dC), 5 ng labelled target DNA (about 20000 Cerenkov c.p.m.) in a final volume of 50 lal binding buffer (20 mM-HEPES pH 7.9, 0.1 M-KCI, 0-2 mM-EDTA, 2 mM-DTT, 20% glycerol). After incubation on ice for 15 min, 50 lal of a solution containing 5 mM-CaC12 and 10 mM-MgC12 was added to each tube. After a 1 min incubation at room temperature the samples were digested with DNase I (Worthington Corporation) for 60 s at 25 °C. For competition experiments up to 500 ng unlabelled NCR fragments were added to the reaction mixture 10 min prior to the labelled fragment.
Exo III footprinting (Wu, 1985) was done according to a modified protocol of Hennighausen & Lubon (1987) .
Gel retardation analysis.
Band shift assays were performed as described by Fried & Crothers (1981) and modified by Schneider et al. (1986) . A 104 Cerenkov c.p.m, equivalent of 32p-labelled oligonucleotide was incubated with 10 ~tg nuclear extract and 0.5 to 6 lag poly(dIdC).poly(dl-dC) in a total volume of 20 lal binding buffer (10 mM-HEPES pH 7.9, 2 mM-MgClz, 0.1 mM-EDTA, 0.25 m~-DTT 0.1 mr, lspermidine, 5 lag BSA, 5% glycerol) and different amounts of homologous or heterologous unlabelled oligonucleotides for competition experiments. After 20 min at room temperature the samples were electrophoresed in 5% polyacrylamide gels, dried and exposed to Kodak XAR-5 film.
Results

Mapping of DNA-protein interactions within the NCR of HPV-8
The HPV-8 NCR acts as enhancer in fibroblast strains of EV patients and in many carcinoma cell lines (Fuchs & Pfister, 1990) . As no cell lines have so far been established from EV patients, for the purpose of this analysis we chose HeLa cells as the source of nuclear proteins. To identify and map the sites of primary DNAprotein interactions within the HPV-8 NCR, a set of overlapping subfragments was subjected to DNase I footprinting analysis. The experiments revealed numerous protected sequences along the entire region analysed. Using competition tests with an excess of nonlabelled homologous target sequences it could be shown that the respective interactions occur in a sequence-specific manner. Fig. 1 shows a representative example of this analysis. Eighteen footprints were identified on both strands of the HPV-8 NCR and designated fp 8-1 to fp 8-18 (Fig. 2) .
A group of footprints (fp 8-6 to 8-10 and 8-14) covers the sequences TTGGC or CTGGC which represent a part of the nuclear factor 1 (NF1) binding site TTGGCT(N3)AGCCAA (Gronostajski, 1986) . These 'half-NF1 sites' were shown to bind NF1 and to mediate its regulatory effects also in papillomaviruses (Gloss et al., 1989b) . In most cases the NFl-binding sites in the HPV-8 NCR are centrally located within a broad footprint. Only with fp 8-10 did the protected domain correspond exactly to the core sequence. Fp 8-14 covers a NF1 site and extends over the HPV-specific equivalent of the CAAT box.
The sequences protected by footprint 8-2 include the motif TGACTCA, known as a binding site of transcription factor(s) API (Angel et aL, 1987) . We confirmed the capacity of this element to interact with AP1 by demonstrating a sequence-specific complex between a corresponding double-stranded oligonucleotide (O. M44-8) and affinity-purified AP1 protein from HeLa cells in gel retardation tests (not shown). Also, interestingly, the E 2 -b i n d i n g palindromes P2 and particularly P3 bind nuclear H e L a proteins (fp 8-4 and 8-12). The b a n d shift analysis with the oligonucleotide O. P2-8, which corresponds to the p a l i n d r o m e P2, revealed a single sequence-specific D N A -p r o t e i n complex (not shown).
Interactions of HPV-8 NCR with nuclear proteins
Sequences partially included in fp 8-4 display some similarity to the b i n d i n g sites of transcription factor Sp 1. The active role of this factor in the regulation of transcription in HPV-16 has been reported recently by Gloss & Bernard (1990) . To test for a possible interaction of Spl with the regulatory sequences of HPV-8 we r a n 
Comparison of protein binding to the EV-specific sequence motifs in HPV-8 and -19
Assuming an important regulatory role of the characteristic sequence elements in the NCRs of EV viruses we compared protein binding to the M33, M29 and A/T motifs of HPV-8 and -19. By using DNase I protection assays, two footprints could be identified within the M33 motif of HPV-19 (Fig. 3) , covering the central and right part of M33 and extending into the T-proximal AP 1 site.
They are equivalent to fp 8-1 and fp 8-2 of HPV-8. Footprints 8-2 and 19-2 probably represent multicomportent, merged complexes including AP1 (Fig. 3) . From DNase I footprint experiments with HPV-8 it became clear that DNA-protein interactions are rather weak in the centre of fp 8-2, which represents the last three nucleotides of M33 and the transition to the AP1 site. The latter sequence stretch shows some variation between EV-associated viruses. However, a band shift analysis with the corresponding oligonucleotides of HPV-5, -8 and -19 revealed one specific complex each. Although the complex was extremely weak in the case of HPV-19, the HPV-19 oligonucleotide was well able to compete for the respective protein with the HPV-8-specific one (Fig. 4) . This indicates that the individual nucleotide exchanges within this region do not severely affect the specificity of protein binding but may lead to substantial differences in affinity.
Only one protected region of 9 nucleotides (nt) could be found in M29 of HPV-19, which is shifted by only three nucleotides relative to that of HPV-8 (Fig. 5) . According to band shift data with the corresponding HPV-8-specific oligonucleotide (O. M29-8) a single protein seemed to interact at this site (Fig. 6) .
Whereas the footprint analysis of the A/T box in HPV-8 suggested weak DNA-protein interactions overlapping the whole motif (fp 8-17, Fig. 5 ), no clear evidence of protein binding was obtained with HPV-19. We screened both regions using an Exo III assay, a highly sensitive method for the mapping of 3' boundaries of protein-binding sequence domains. It could be confirmed that the A/T box of HPV-8 is clearly involved in binding of nuclear proteins. In contrast, no such interactions took place within the corresponding sequences of HPV-19. In the case of HPV-8, band shift analyses showed three specific DNA-protein complexes (not shown).
Discussion
Our study demonstrated the non-coding regulatory sequences of two EV-associated HPV types to be involved in numerous sequence-specific interactions with nuclear proteins of epithelial HeLa cells. In DNase I footprint assays an average of 60% of both DNA strands within the NCR was protected against the nuclease by bound cellular factors. This high density of protein-binding sites agrees with the values reported previously for the entire NCRs of HPV-16 and -18 (Gloss et at., 1989a; Sibbet & Campo, 1990; Garcia-Carranca et al., 1988) , although EV-and genital mucosa-specific HPVs differ clearly in the length and organization of their regulatory regions (Iftner, 1990 Eighteen DNase I footprints (fp8-1 to fp8-18) could be identified in the NCR sequences of HPV-8. An examination of the same region with more sensitive Exo III tests revealed in some cases the occurrence of specific Exo III stops within sequences protected in the DNase I assays (not shown). This suggests that some of the DNase I footprints are in fact clusters of individual binding sites. The majority of identified DNA-protein interactions occur either at recognition sequences of known regulatory proteins or within motifs specifically conserved in the NCRs of EV-associated virus types. To the first category belong NF1 and API sites as well as a papillomavirus equivalent of the CAAT box (Schwarz et al., 1983) , which are consistent components of the NCR in all HPVs studied so far.
Interactions of HPV-8 NCR with nuclear proteins
We could demonstrate the involvement of all seven NF1 motifs of HPV-8 in DNA-protein interactions. Interestingly, with the exception of fp 8-10, all footprints encompasing these sites extend broadly beyond the 5 bp NF1 'half-site' core. This could be due to either steric effects of bound NF1 protein(s) or, considering the size of additionally protected proximal sequences, more probably to their interactions with other nuclear factors. This may be certainly the case with the CAAT-like box (fp 8-14), known to cooperate with several proteins (Johnson & McKnight, 1989) .
The APl-binding site TGACTCA (Angel et al., 1987 ) represents a part of fp 8-2. The AP1 elements in the NCRs of HPV-16 and -18 were shown to contribute to the overall enhancer or promoter activities, respectively (Chan et al., 1990; Cripe et al., 1990; Offord & Beard, 1990) . Also in HPV-8, a mutation of the AP1 motif clearly led to a decrease of the enhancer activity (R. Zimmermann, unpublished results).
Since HeLa ceils do not produce any functional viral E2 trans-activator protein, it was surprising to find footprints (fp 8-3, 8-4, 8-12) overlapping with or almost completely covering its two palindromic binding sites P2 Stenlund & Botchan (1990) described competition of E2 for the binding site of a cellular protein, which positively affects the acitivty of the bovine papiUomavirus type 1 (BPV-1) P1 promoter. Footprints with cellular proteins also occur at E2-specific palindromes in HPV-16 (Gloss et al., 1989a) and BPV-4 (Jackson & Campo, 1991) , which makes it possible that such interactions represent a more common regulatory mechanism among papillomaviruses. The sequence within P2 partially protected by fp 8-4 is similar to an Spl binding site. Such aberrant Spl sites ( N G G N G N ) in the NCRs of genital HPVs interact with the Spl protein and influence the activity of the early HPV-16 promoter (Gloss & Bernard, 1990) . We failed, however, to confirm the binding of purified Spl to the NCR of HPV-8. This suggests that Spl does not compete with E2 at the HPV-8 P2 palindrome and does not necessarily bind to sequence N G G N G N on its own. It has been shown recently that Spl can interact with the E2 protein of BPV-1 and target it into a promoter region (Li et al., 1991) . In view of our results, however, if a similar mechanism is active in HPV-8, some other factor(s) must substitute for the Spl protein.
The middle part of footprint 8-13 displays a sequence ATGAAAAT which represents one of the octamerbinding sites in the human IgH gene enhancer (Parslow et al., 1984; Maeda et al., 1987) . The octamer elements regulate the cell-specific expression of the immunoglobulin genes and occur also in the regulatory units of many non-lymphoid genes. These elements can interact with a variety of cell-specific and ubiquitous protein factors (Johnson & McKnight, 1989) . Royer et al. (1991) have recently demonstrated the binding of an octamer-like factor to the sequences of an HPV-18 enhancer.
Within the M33 motifs of HPV-8 and -19 the binding of HeLa nuclear proteins was limited to the Ll-distant moieties. The engaged M33 sequences were part of a large protected region, extending further to the respective AP1 sites. Three single base exchanges occurring at the boundary between M33 and AP1 could be shown to result in a notable difference in the affinity of the protein factor, which interacts with this special region. Inspection of the M33 sequence protected in the DNase I assay revealed 10 bp upstream of the AP1 site a motif, AAGGAATGTT, which is very similar to the simian virus 40 enhanson GT-IIC as well as to the PEA3 site of the polyomavirus enhancer (Zenke et al., 1986; Martin et al., 1988) . The PEA3-binding factors have recently been shown to belong to the c-ets oncogene family . It is interesting to note that the PEA3 and AP1 elements are linked in the control regions of several promoters (Gutman & Wasylyk, 1990; Rorth et al., 1990) . They may synergistically cooperate in transcription regulation and were described by Gutman & Wasylyk (1990) as 'TPA-and oncogene-responsive units'.
Almost identically located footprints were identified within M29 of HPV-8 and -19. According to get retardation data for HPV-8, a single protein most probably interacts with this element. No obvious similarities could be found when comparing the protected sequence with the binding sites of known transcription-regulating proteins.
It should be realized that major parts of M33 and M29 were not protected in spite of being highly conserved. One might expect that these sequences interact with proteins that are expressed in a cell type-and/or differentiation-specific manner.
The A/T box of many EV-specific HPVs is an interesting sequence element, only rarely occurring in other viruses. The core of the A/T box in HPV-8 consists of four TAAA repeats followed by 12 alternating As and 
